Witte Owen N.
Director at ALLO; Director at Kite Pharma, Inc.
- Sold, on record
- $3.7M
- Dollars the filings state
- Form 4 sales
- 7
- Latest Aug 12, 2022
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- ALLOAllogene Therapeutics, Inc.Director
- Kite Pharma, Inc.Director
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- ALLO64,969 shares
- Kite Pharma, Inc.25,000 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale Kite Pharma, Inc.Plan not statedJun 26 2017
Sold 25,000 shares at $100.30 ($2.5M)
Witte Owen N., Director
Sold 24.7% of holdings ($10.2M position)76,250 shares leftFirst sale on recordFiling
- 2 Form 4 sale ALLOPlan not statedJun 9 +1444 days
Sold 9,969 shares at $25.05 ($250k)
Witte Owen N., Director
Sold 4% of holdings ($6.2M position)236,182 shares leftFirst sale on recordFiling
- 3 Form 4 sale ALLOPlan not statedAug 20 +72 days
Sold 10,000 shares at $23.47 ($235k)
Witte Owen N., Director
Sold 4.2% of holdings ($5.5M position)226,182 shares leftFiling
- 4 Form 4 sale ALLOPlan not statedSep 9 +20 days
Sold 5,000 shares at $25.54 ($128k)
Witte Owen N., Director
Sold 2.2% of holdings ($5.8M position)221,182 shares leftFiling
- 5 Form 4 sale ALLOPlan not statedJun 22 +286 days
Sold 10,000 shares at $11.76 ($118k)
Witte Owen N., Director
Sold 4.1% of holdings ($2.9M position)233,271 shares left1x usual sizeFiling
- 6 Form 4 sale ALLOPlan not statedAug 12 +51 days
Sold 15,000 shares at $16.75 ($251k)
Witte Owen N., Director
Sold 6.4% of holdings ($3.9M position)218,271 shares left1.5x usual sizeFiling
- 7 Form 4 sale ALLOPlan not statedAug 12 same day
Sold 15,000 shares at $16.75 ($251k)
Witte Owen N., Director
Sold 6.4% of holdings ($3.9M position)218,271 shares left1.5x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (7)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Aug 12, 2022 | ALLO | Director | Form 4 sale | 15,000 | $251k | 6.4% | Plan not stated | SEC |
| Aug 12, 2022 | ALLO | Director | Form 4 sale | 15,000 | $251k | 6.4% | Plan not stated | SEC |
| Jun 22, 2022 | ALLO | Director | Form 4 sale | 10,000 | $118k | 4.1% | Plan not stated | SEC |
| Sep 9, 2021 | ALLO | Director | Form 4 sale | 5,000 | $128k | 2.2% | Plan not stated | SEC |
| Aug 20, 2021 | ALLO | Director | Form 4 sale | 10,000 | $235k | 4.2% | Plan not stated | SEC |
| Jun 9, 2021 | ALLO | Director | Form 4 sale | 9,969 | $250k | 4.0% | Plan not stated | SEC |
| Jun 26, 2017 | Kite Pharma, Inc. | Director | Form 4 sale | 25,000 | $2.5M | 24.7% | Plan not stated | SEC |